Paediatric oncologist Dr. Antony Michalski specializes on tumors of the central nervous system. Since 1993, he has served as a consultant at Great Ormond Street Hospital (GOSH). He is the team leader of a multidisciplinary group dedicated to providing excellent results and patient-centered care. Dr. Michalski is particularly interested in treating kids who have brain and spinal cord tumors. He is particularly interested in tumors that develop in very young infants and primitive neuroectodermal tumors in childhood. degrees included include MB ChB, MRCP, PhD, and FRCPCH. Prior to being hired as a registrar at GOSH, Dr. Michalski received his paediatrics training in Birmingham and London. Before returning to GOSH for more oncology training, he completed a year of training at the Children's Hospital of Philadelphia. At the Institute of Child Health, he completed his dissertation in molecular oncology. He presently serves as GOSH's neuro-oncology lead.

Qualification

• MB ChB
• MRCP
• PhD
• FRCPCH

Dr Vikas Dua is Pediatric Hemato Oncologist and bone marrow transplant specialist of the generation. Dr. Dua's results in the field of Pediatric Hematology Oncology and BMT have been some of the best. He and his team has done 1000+ pediatric transplants. He is known for his excellent outcome in stem cell transplant specially in Pediatric haploidentical transplant and he has done some of the very rare transplants which nobody else has done in India. He has received Fellowship in Pediatric BMT, NUH, Singapore

Qualification

• MBBS
• MD
• Fellowship

In the Cumming School of Medicine's Charbonneau Cancer Center and Alberta Children's Hospital Research Institute, Dr. Douglas Mahoney works as a translational scientist. He has made significant contributions over the past 15 years to the development of numerous cancer immunotherapies that are currently being explored in human clinical trials. In order to create ""designed viruses"" that elicit anticancer immunity and enhance Chimeric Antigen Receptor (CAR) T-cell treatment of cancer, his lab is currently concentrating on understanding how rhabdoviruses interact with immune cells. His lab collaborates with top genomics and immunology labs in Alberta and uses cutting-edge synthetic biology, high-resolution in vivo imaging, and robotic screening technologies, among other approaches. A brand-new research programme named ACTION (Alberta Cellular Therapy and Immune Oncology), which was established in collaboration with the Canadian Cancer Society in 2020, has Dr. Mahoney as its Scientific Director. Doug's team at ACTION is working to create revolutionary next-generation tailored T cell treatments against fresh targets found on solid tumours with a high mortality rate.

Qualification

• MD
• PhD

Qualification

• MD. Pediatric Oncology
• National Cancer Institute
• Cairo University. MSc. General Pediatrics
• Faculty of Medicine
• Cairo University. BSc. Medicine and Surgery
• Faculty of Medicine
• Cairo University

Qualification

• MD. Pediatric Oncology
• National Cancer Institute
• MSc. Pediatrics
• Faculty of Medicine
• BSc. Medicine and Surgery
• Faculty of Medicine
• Cairo University.

Dr. Sirisha Rani received her MD in Pediatrics from Premiere Institute PGIMER in Chandigarh, where she also received a prize for being the best departing student. DNB was obtained later from the National Board of Examination. worked as a senior resident at St. John's Hospital before moving on to Kidwai Memorial Cancer Institute in Bangalore. Then, to continue my education in paediatric hematology-oncology and BMT, I travelled to the United Kingdom. She worked in prestigious institutions in the UK as Cardiff University, Bristol Children's Hospital, and Great Ormond Street Hospital in London. In Banjara Hills, Hyderabad's Rainbow Children's Hospital, Senior Consultant in Pediatric Hematology-Oncology and BMT is now employed. The National Board has granted Rainbow Children's Hospital accreditation for the FNB training programme in paediatric hematology-oncology in recognition of the wide range and volume of paediatric oncology and haematology cases seen in the department of paediatric hematology-oncology.

Qualification

• MD (Peds) (PGIMER)
• DNB
• MRCPCH (UK)
• Fellow in Pediatric Hemato Oncology and Bone Marrow Transplantation (UK)

A fellowship in haematology, oncology, and brain tumours was awarded to PROFESSOR SURADEJ HONGENG, M.D. from the United States, and he holds a medical degree from the American board of paediatric haematology and oncology. In addition to being a co-investigator on a project with the group at the National institute of health, he is the primary investigator of clinical research at numerous hospitals and institutions in Thailand (US). His 45 research papers have been published internationally as well as in Thailand.

Qualification

• M.D.
• Mahidol University
• Thailand
• Diploma- Thai Board of Pediatrics
• Fellowships: Hematology
• Oncology
• Diploma-American Board of Pediatrics
• Diploma- The American Board of Pediatric Hematology/Onco

The University of Queensland served as Dr. Mitchell's last medical school, and Sydney Children's Hospital served as his paediatric residency. He had two clinical fellowships in paediatric bone marrow transplantation while specialising in paediatric haematology/oncology at the University of Minnesota in the United States and Memorial Sloan Kettering Cancer Center in the United States. At the moment, Dr. Mitchell works as a paediatric hematologist/oncologist at the Sydney Children's Hospital Kids Cancer Centre.

Qualification

• B.Sc (Mol Biol)
• MBBS
• FRACP